-
-
-
-
-
-
-
Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results
-
-
-
-
-
-
-
Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results
-
-
-
-
-
-
-
Generation Bio Presents Preclinical Data Demonstrating Broad Potential of Gene Therapy Platform at ASGCT and Reports First Quarter Financial Results
-
-
-
-
-
-
-
Generation Bio (GBIO) PT Raised to $29 at JPMorgan, Following Earnings
-
-
974,595 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All